HALO
Halozyme Therapeutics Inc
$68.52
-0.67% ($0.46)
Volume
1.75M
52W High
$82.22
52W Low
$51.06
Market Cap
$7.66B
Next Earnings Report
Last Reported
May 12, 2026 Missed
Actual: $1.22
vs. Consensus: $1.76
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 12, 2026
1-Day:
-1.27%
Q1 2026
May 11, 2026
1-Day:
+6.81%
Q1 2026
May 5, 2026
1-Day:
+0.73%
Q4 2025
Feb 24, 2026
1-Day:
-0.01%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $451.8M | +51.6% | 77.4% | 56.3% | -$141.6M |
| Q3'25 | $354.3M | +22.1% | 84.4% | 61.5% | $175.2M |
| Q2'25 | $325.7M | +40.8% | 85.8% | 62.2% | $165.2M |
| Q1'25 | $264.9M | +35.2% | 81.7% | 53.4% | $118.1M |
| Q4'24 | $298.0M | +29.6% | 85.9% | 58.9% | $137.0M |
| Q3'24 | $290.1M | +34.3% | 83.0% | 56.3% | $137.0M |
| Q2'24 | $231.4M | +4.7% | 75.2% | 50.7% | $93.2M |
| Q1'24 | $195.9M | +20.8% | 76.5% | 48.8% | $76.8M |
Company Information
Symbol
HALO
Company
Halozyme Therapeutics Inc
Market Cap
$7.66B